Data as of Dec 06
| +0.39 / +2.09%|
The 4 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 35.50, with a high estimate of 39.00 and a low estimate of 30.00. The median estimate represents a +86.65% increase from the last price of 19.02.
The current consensus among 5 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.